⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4914089 | 1.00 | CES2 (0.67) | — | |
| SCHEMBL61183 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL17493405 | 0.98 | CES2 (0.64) | — | |
| SCHEMBL16143265 | 0.98 | CES2 (0.64) | — | |
| SCHEMBL31357681 | 0.98 | CES2 (0.64) | — | |
| SCHEMBL9094627 | 0.98 | CES2 (0.64) | — | |
| SCHEMBL9064565 | 0.98 | CES2 (0.64) | — | |
| Ammonia Solution, Strong SCHEMBL902138 | 0.98 | CES2 (0.64) | — | |
| Hydrochloric Acid SCHEMBL1704886 | 0.98 | CES2 (0.64) | — | |
| SCHEMBL31172352 | 0.98 | CES2 (0.64) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 129 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111153931-B | 2-pyridine methane imine tin (II) compound and preparation method and application thereof | 山西大学 | 2021-05-14 | — | — | CN | claimed |
| CN-111153931-A | 2-pyridine methane imine tin (II) compound and preparation method and application thereof | 山西大学 | 2020-05-15 | — | — | CN | claimed |
| EP-1797123-B1 | COMPLEMENTARY PEPTIDES FOR ß-AMYLOID 29-42 PEPTIDE | UNIV LIEGE (BE) | 2010-03-03 | — | — | EP | claimed |
| JP-1175968-A | — | — | None | — | — | JP | disclosed |
| JP-8165239-A | — | — | None | — | — | JP | disclosed |
| US-20260092062-A1 | PYRIDINE CARBOXAMIDE COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS | RECTIFY PHARMACEUTICALS INC (US) | 2026-04-02 | — | — | US | disclosed |
| US-20260092062-A1 | PYRIDINE CARBOXAMIDE COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS | RECTIFY PHARMACEUTICALS INC (US) | 2026-04-02 | — | — | US | disclosed |
| US-20260001861-A1 | PYRIDINE CARBOXAMIDE COMPOUNDS FOR INHIBITING NAV1.8 | LIEBER INST INC (US) | 2026-01-01 | — | — | US | disclosed |
| US-20260001861-A1 | PYRIDINE CARBOXAMIDE COMPOUNDS FOR INHIBITING NAV1.8 | LIEBER INST INC (US) | 2026-01-01 | — | — | US | disclosed |
| US-12486251-B2 | CBP/EP300 inhibitor and use thereof | PHARMABLOCK SCIENCES (NANJING) , INC. (CN) | 2025-12-02 | — | — | US | disclosed |
| EP-4613752-A1 | POLYCYCLIC POLY(ADP-RIBOSE) POLYMERASE SELECTIVE INHIBITOR | Xuanzhu Biopharmaceutical Co., Ltd. (CN) | 2025-09-10 | — | — | EP | disclosed |
| JP-H08165239-A | ANTI-ARTERIOSCLEROTIC AGENT | KIRIN BREWERY CO LTD | 1996-06-25 | — | — | JP | disclosed |
| US-5508293-A | TREATING HYPERTENSION, ANGINA PECTORIS | KIRIN BEER KABUSHIKI KAISHA (JP) | 1996-04-16 | — | — | US | disclosed |
| WO-1995013828-A1 | BENEFICIAL WOUND HEALING APPLICATIONS OF CALRETICULIN AND OTHER HYALURONAN-ASSOCIATED PROTEINS | NEW YORK UNIVERSITY (US) | 1995-05-26 | — | — | WO | disclosed |
| EP-0634400-A1 | PYRIDINECARBOXIMIDAMIDE COMPOUND AND USE THEREOF | KIRIN BEER KABUSHIKI KAISHA (JP) | 1995-01-18 | — | — | EP | disclosed |
| US-5272164-A | Carboximidamide derivatives | KIRIN BEER KABUSHIKI KAISHA (JP) | 1993-12-21 | — | — | US | disclosed |
| US-5240926-A | Fungicides | BAYER AKTIENGESELLSCHAFT (DE) | 1993-08-31 | — | — | US | disclosed |
| EP-0388528-A2 | Carboximidamide derivatives | KIRIN BEER KABUSHIKI KAISHA (JP) | 1990-09-26 | — | — | EP | disclosed |
| JP-H01175968-A | PRODUCTION OF PYRIDINECARBOXYLIC ACID ESTERS | KOEI CHEM CO LTD | 1989-07-12 | — | — | JP | disclosed |
| EP-0065039-A1 | An O-(N-alkoxy-pyridinecarboximidoyl)phosphate, a process for producing the same, and an insecticidal or acaricidal composition containing the same | ISHIHARA SANGYO KAISHA LTD. (JP) | 1982-11-24 | — | — | EP | disclosed |